Literature DB >> 3725180

'Peripheral' benzodiazepine binding sites in human brain and kidney: autoradiographic studies.

A Pazos, U Cymerman, A Probst, J M Palacios.   

Abstract

Benzodiazepine (BZ) recognition sites of the 'peripheral' type were localized autoradiographically in human postmortem brain and kidney using [3H]Ro 5-4864. These sites presented a relatively homogeneous distribution. Areas such as the ependyma, choroid plexus and olfactory bulb, which in the rat are very rich in these binding sites, presented densities in the human brain which were about 1/10 of those seen in the rat. Human tissues presenting gliosis, such as the hippocampi from senile dementia patients, did not show a clear increase in the number of [3H]Ro 5-4864 sites, in contrast with the high densities found in rat brain areas presenting neurotoxin-induced gliosis. Intermediate densities of binding were seen in a human glioblastoma tumor. The human kidney also showed lower densities of peripheral BZ binding sites, when compared to the rat kidney. These results indicate that marked species differences exist in the densities of peripheral BZ sites and that caution has to be exerted when extrapolating data from the experimental animal to human.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3725180     DOI: 10.1016/0304-3940(86)90181-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies.

Authors:  Junchao Tong; Belinda Williams; Pablo M Rusjan; Romina Mizrahi; Jean-Jacques Lacapère; Tina McCluskey; Yoshiaki Furukawa; Mark Guttman; Lee-Cyn Ang; Isabelle Boileau; Jeffrey H Meyer; Stephen J Kish
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-20       Impact factor: 6.200

2.  Platelet phenolsulphotransferase activity, monoamine oxidase activity and peripheral-type benzodiazepine binding in demented patients.

Authors:  P Bongioanni; M Donato; M Castagna; F Gemignani
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Synthesis and evaluation of 11C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography.

Authors:  K Hashimoto; O Inoue; K Suzuki; T Yamasaki; M Kojima
Journal:  Ann Nucl Med       Date:  1989-07       Impact factor: 2.668

4.  Reduced affinity of peripheral benzodiazepine binding sites in elderly insomniac patients.

Authors:  J C Gilbert; D Valtier; R Huguet; C Hulin; J P Aquino; P Meyer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Early developmental exposure to benzodiazepine ligands alters brain levels of thiobarbituric acid-reactive products in young adult rats.

Authors:  R C Miranda; J P Wagner; C K Kellogg
Journal:  Neurochem Res       Date:  1989-11       Impact factor: 3.996

6.  Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation.

Authors:  Masahiro Fujita; Masao Imaizumi; Sami S Zoghbi; Yota Fujimura; Amanda G Farris; Tetsuya Suhara; Jinsoo Hong; Victor W Pike; Robert B Innis
Journal:  Neuroimage       Date:  2007-11-22       Impact factor: 6.556

7.  Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06.

Authors:  Yota Fujimura; Sami S Zoghbi; Fabrice G Simèon; Andrew Taku; Victor W Pike; Robert B Innis; Masahiro Fujita
Journal:  J Nucl Med       Date:  2009-06-12       Impact factor: 10.057

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.